<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>cQT | CSE Tracker</title>
    <link>https://master--youthful-lamport-190a0e.netlify.app/tag/20210323cqt/</link>
      <atom:link href="https://master--youthful-lamport-190a0e.netlify.app/tag/20210323cqt/index.xml" rel="self" type="application/rss+xml" />
    <description>cQT</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Tue, 23 Mar 2021 08:30:00 -0800</lastBuildDate>
    <image>
      <url>https://master--youthful-lamport-190a0e.netlify.app/images/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_2.png</url>
      <title>cQT</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/tag/20210323cqt/</link>
    </image>
    
    <item>
      <title>Cardiac Safety from Preclinical to the Clinic â€“ Industry and Regulatory Trends in T-QT and Concentration-QT Studies for Assessing QT Prolongation Risks</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/webinar/20210323cardiac-safety-from-preclinical-to-the-clinic-industry-and-regulatory-trends-in-t-qt-and-concentration-qt-studies-for-assessing-qt-prolongation-risks/</link>
      <pubDate>Tue, 23 Mar 2021 08:30:00 -0800</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/webinar/20210323cardiac-safety-from-preclinical-to-the-clinic-industry-and-regulatory-trends-in-t-qt-and-concentration-qt-studies-for-assessing-qt-prolongation-risks/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Symposium Agenda (All times are in Pacific Time)&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Day 1: March 23, 2021&lt;/strong&gt;&lt;br&gt;
&lt;span style=&#34;color:grey&#34;&gt;
&lt;em&gt;8:30-8:45am:&lt;/em&gt; Introductions&lt;br&gt;
&lt;em&gt;8:45-9:30am:&lt;/em&gt; State-of-the-Art: TQT studies (QT and C-QT Analyses, Challenges &amp;amp; Examples) - Borje Darpo (ERT)&lt;br&gt;
&lt;em&gt;9:30-10:15am:&lt;/em&gt; Cardiac safety and TQT waivers (Types of studies - FIH, Food effect, DDI and timing, Issues with ECG collection) - Jay Mason (Spaulding)&lt;br&gt;
&lt;em&gt;10:15-10:25am:&lt;/em&gt; Sponsor Presentation&lt;br&gt;
&lt;em&gt;10:25-10:40am:&lt;/em&gt; Break&lt;br&gt;
&lt;em&gt;10:40-11:25am:&lt;/em&gt; TBD&lt;br&gt;
&lt;em&gt;11:25am-12:10pm:&lt;/em&gt; New opportunities for C-QT and C-QT in non-ideal scenarios - Lauren Lohmer (Nuventra)&lt;br&gt;
&lt;em&gt;12:10pm-12:40pm:&lt;/em&gt; Panel Discussion&lt;br&gt;
&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Day 2: March 24, 2021&lt;/strong&gt;&lt;br&gt;
&lt;span style=&#34;color:grey&#34;&gt;
&lt;em&gt;8:30-8:45am:&lt;/em&gt; Introductions&lt;br&gt;
&lt;em&gt;8:45-9:30am:&lt;/em&gt; Case Study - Biologics C-QT project supporting a major readout - Yehong Wang (Genentech)&lt;br&gt;
&lt;em&gt;9:30-10:15am:&lt;/em&gt; TBD&lt;br&gt;
&lt;em&gt;10:15-10:25am:&lt;/em&gt; Sponsor Presentation&lt;br&gt;
&lt;em&gt;10:25-10:40am:&lt;/em&gt; Break&lt;br&gt;
&lt;em&gt;10:40-11:25am:&lt;/em&gt; Non-clinical aspects related to the ICH Q&amp;amp;A - Anne Bonneville (Terns Pharmaceuticals)&lt;br&gt;
&lt;em&gt;11:25pm-12:05pm:&lt;/em&gt; Panel Discussion 
&lt;/span&gt;&lt;/p&gt;</description>
    </item>
    
  </channel>
</rss>
